Related Experiment Video
Updated: Apr 10, 2026

Combustion Characterization and Model Fuel Development for Micro-tubular Flame-assisted Fuel Cells
Published on: October 2, 2016
Automated gas control with the Maquet FLOW-i
Rik Carette1, Andre M De Wolf2, Jan F A Hendrickx3
1Department of Anesthesiology, Intensive Care and Pain Therapy, OLV Hospital, Moorselbaan 164, 9300, Aalst, Belgium.
Automated Gas Control (AGC) on the FLOW-i anesthesia machine effectively manages inspired oxygen and anesthetic concentrations. Lower speeds reduce sevoflurane usage, minimizing waste and cost while maintaining patient safety.
Area of Science:
- Anesthesiology
- Medical Devices
- Pharmacology
Background:
- The FLOW-i anesthesia machine features Automated Gas Control (AGC) for precise management of inspired oxygen concentration (FIO2) and end-expired anesthetic concentration (FA).
- AGC utilizes automated low flow techniques with target-controlled delivery of potent inhaled anesthetics like sevoflurane.
- Understanding AGC's performance and quantitative aspects is crucial for optimizing anesthetic delivery and resource utilization.
Purpose of the Study:
- To evaluate the performance and quantitative characteristics of the Automated Gas Control (AGC) feature on the FLOW-i anesthesia machine.
- To compare the impact of different AGC speed settings on anesthetic agent usage, physiological parameters, and time to target concentration.
- To assess the potential of AGC to reduce anesthetic waste, cost, and environmental pollution.
Main Methods:
- Twenty-four ASA I-II patients undergoing abdominal or gynecological surgery received sevoflurane anesthesia with AGC.
- Patients were randomized into three groups (n=8 each) assigned to AGC speeds 2, 4, or 6.
- Key parameters including FIO2, end-expired sevoflurane (FAsevo), BIS values, vital signs, and sevoflurane consumption were monitored over 60 minutes.
Main Results:
- Target FIO2 was achieved within 1-2 minutes in all groups. Target FAsevo was reached more rapidly with higher AGC speeds.
- FAsevo reached 1.8-1.9% within 6-15 minutes across groups. No significant differences in blood pressure, heart rate, or BIS values were observed.
- Cumulative sevoflurane usage was significantly lower with lower AGC speeds, particularly after 30 minutes and between 35-60 minutes for the slowest speed.
Conclusions:
- Automated Gas Control (AGC) on the FLOW-i anesthesia machine effectively controls FIO2 and FAsevo, with faster speeds achieving targets sooner.
- Lower AGC speeds significantly reduce sevoflurane consumption, approaching near closed-circuit conditions with maintenance fresh gas flow of 300 mL/min.
- AGC offers a valuable tool for reducing anesthetic waste, cost, and pollution while simplifying low-flow anesthesia management.
Related Concept Videos
Bioreactor Controls-I
Gas Chromatography: Sample Injection Systems
Two primary injection methods are used...
Bioreactor Controls-II
Pipe Flowrate Measurement
The orifice meter is a simple,...
Pipe Flowrate Measurement: Problem Solving

